Transactions
5
Insider / CLOROX CO /DE/
Charter Julia
Director at CLOROX CO /DE/
- Company
- CLOROX CO /DE/
- Ticker
- CLX
- First filing on record
- January 5, 2026
- Latest trade on record
- December 31, 2025
- SEC filings
- EDGAR ↗
Charter Julia, Director at CLOROX CO /DE/, has disclosed 5 transactions in CLX since January 5, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed January 5, 2026, 5 days after the trade; 5 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
0
Avg. disclosure lag
152.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Charter Julia reported 2 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 5 | 1,747 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2025 | 5 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CLX | Other A | December 31, 2025 | January 5, 2026 | 5d | 1,638 | — | — | latederivative | Form 4 ↗ | |
| CLX | Other A | November 6, 2025 | January 5, 2026 | 60d | 33 | — | — | latederivative | Form 4 ↗ | |
| CLX | Other A | August 29, 2025 | January 5, 2026 | 129d | 29 | — | — | latederivative | Form 4 ↗ | |
| CLX | Other A | May 9, 2025 | January 5, 2026 | 241d | 25 | — | — | latederivative | Form 4 ↗ | |
| CLX | Other A | February 14, 2025 | January 5, 2026 | 325d | 22 | — | — | latederivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| January 5, 2026 | Form 4 | 0001225208-26-000173 | 5 | published | EDGAR ↗ |
Other insiders at CLOROX CO /DE/
- WEINER RUSSELL J Chief Executive Officer 21 rows
- WILLIAMS CHRISTOPHER J Director 21 rows
- Breber Pierre R Director 15 rows
- Plaines Stephanie Director 12 rows
- Hyder Chris T EVP-Group Pres -Hlth & Hyg 11 rows
- Shattock Matthew J Director 11 rows
- Bellet Luc EVP - Chief Financial Officer 9 rows
- Hilt Angela C EVP - Chief Legal Officer 9 rows
- Marriner Kirsten EVP - Chief Admin Officer 9 rows
- Rendle Linda J Director 9 rows
Everyone on file, with contracts and lobbying under the company's name: CLOROX CO /DE/.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 5 | January 5, 2026 | January 5, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.